Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
SymBio Pharmaceuticals Limited (Japan)
Homepage:
symbiopharma.com
Alternate name:
SymBio Pharmaceuticals Limited
ROR:
02g42wq61
OpenAlex ID:
I4405267378
Preliminary Results of a Phase 2a Clinical Trial to Evaluate Safety, Tolerability and Antiviral Activity of Intravenous Brincidofovir (BCV IV) in Immunocompromised Patients with Adenovirus Infection
2024
·
Michael Grimley
, Gabriela M. Marón
, et al.
·
Transplantation and Cellular Therapy
·
13
Preliminary Results of a Phase 2a Clinical Trial to Evaluate Safety, Tolerability and Antiviral Activity of Intravenous Brincidofovir (BCV IV) in Immunocompromised Patients with Adenovirus Infection
2023
·
Michael Grimley
, Gabriela Maron
, et al.
·
Blood
·
10
Sensitivity of Human Mastadenovirus, the Causal Agent of Pharyngoconjunctival Fever, Epidemic Keratoconjunctivitis, and Hemorrhagic Cystitis in Immunocompromised Individuals, to Brincidofovir
2022
·
Nozomu Hanaoka
, Masatoshi Hazama
, et al.
·
Microbiology Spectrum
·
9
Bendamustine plus rituximab in Japanese patients with relapsed or refractory diffuse large B-cell lymphoma
2022
·
Kayoko Murayama
, Toru Kiguchi
, et al.
·
Annals of Hematology
·
8
PDF
Broad-spectrum antiviral brincidofovir inhibits Epstein-Barr virus and related gammaherpesvirus in human and nonhuman primate cells
2025
·
Abaigeal Donaldson
, Madeleine R. Druker
, et al.
·
Journal of Clinical Investigation
·
4
PDF
Brincidofovir inhibits polyomavirus infection in vivo
2024
·
Arrienne B. Butic
, Zoe E. Katz
, et al.
·
mBio
·
4
P-103. Adenoviremia Clearance Following Treatment with Intravenous (IV) Brincidofovir (BCV) in Immunocompromised Patients is Associated with Positive Clinical Disease Response: Preliminary Outcomes from the ATHENA Phase IIa Study
2025
·
Gabriela Maron
, Michael J Boeckh
, et al.
·
Open Forum Infectious Diseases
·
3
Oral formulation of bendamustine hydrochloride for patients with advanced solid tumors; a phase 1 study
2022
·
Toshio Shimizu
, Kazuhiko Nakagawa
, et al.
·
Investigational New Drugs
·
2
PDF
A phase I/II study of 10-min dosing of bendamustine hydrochloride (rapid infusion formulation) in patients with previously untreated indolent B-cell non-Hodgkin lymphoma, mantle cell lymphoma, or relapsed/refractory diffuse large B-cell lymphoma in Japan
2022
·
Kenichi Ishizawa
, Masahiro Yokoyama
, et al.
·
Cancer Chemotherapy and Pharmacology
·
2
PDF
Abstract 3043: Preclinical efficacy assessment of brincidofovir against glioblastoma
2025
·
Kyounghee Seo
, Tomoko Ozawa
, et al.
·
Cancer Research
·
1
Therapeutic Repurposing of Brincidofovir in Natural Killer/T-Cell Lymphoma Reveals Potent Induction of Replication Stress, Sting Pathway Activation and Immunogenic Cell Death
2022
·
Jason Yongsheng Chan
, Elizabeth Chun Yong Lee
, et al.
·
Blood
·
1
Preclinical evaluation of Brincidofovir in glioblastoma demonstrates improved long term-survival and cytomegalovirus-dependent and independent effects
2026
·
Noe B. Mercado
, Philippa Vaughn-Beaucaire
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Preclinical efficacy of the anti-EBV agent brincidofovir (BCV) in EBV-associated gastric carcinoma (EBVaGC).
2026
·
Tetsu Kamitani
, Masatoshi Hazama
, et al.
·
Journal of Clinical Oncology
Preclinical activity of brincidofovir in peripheral T-cell and NK/T-cell lymphoma
2026
·
Jason Yongsheng Chan
, Elizabeth Chun Yong Lee
, et al.
·
BMC Medicine
Feasibility of Salvage Therapy With High-Dose Bendamustine and Rituximab Based on a Series of Two Cases From a Planned Phase II Trial for Relapsed/Refractory Diffuse Large B-cell Lymphoma
2026
·
Kazunori Murai
, Yashushi Hiramatsu
, et al.
·
Cureus
PDF
EXTH-54. In vivo characterization of preclinical efficacy of brincidofovir against glioblastoma
2025
·
Sol Beccari
, Tomoko Ozawa
, et al.
·
Neuro-Oncology
PDF
1394P Preclinical efficacy of brincidofovir (BCV) against head and neck squamous cell carcinoma (HNSCC)
2025
·
T. Kamitani
, M. Hazama
·
Annals of Oncology
Therapeutic Repurposing of Brincidofovir in Non-Hodgkin Lymphoma - Potential Synergy with Immune Checkpoint Blockade
2024
·
Jason Yongsheng Chan
, Elizabeth Chun Yong Lee
, et al.
·
Blood
PDF
Abstract 7276: Potent anti-proliferative activity of brincidofovir in Diffuse Large B-cell Lymphoma with overexpression of transcriptional repressor TLE1
2024
·
Jing Yi Lee
, Tun Kiat Ko
, et al.
·
Cancer Research
Brincidofovir induces potent anti‐tumor activity in MYC‐driven Natural Killer/T‐cell Lymphoma with loss of transcriptional repressor TLE1
2023
·
J. Y. Chan
, E. C. Y. Lee
, et al.
·
Hematological Oncology
PDF
MO12-5 Phase III trial of bendamustine plus rituximab for relapsed or refractory diffuse large B-cell lymphoma in Japan
2021
·
Toru Kiguchi
, Yasuhito Terui
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
21
Citation count:
57
Year
Topic
Type